Ligand-Induced Phosphorylation of the Colony-Stimulating Factor 1 Receptor Can Occur through an Intermolecular Reaction That Triggers Receptor Down Modulation

Literature Cited

• Anderson, S. J., M. A. Gonda, C. W. Rettenmier, and C. J. Sherr. 1984. Subcellular localization of glycoproteins encoded by the viral oncogene v-fms. J. Virol. 51:730–741.
   PubMedGoogle Scholar
• Ashmun, R. A., A. T. Look, W. M. Roberts, M. F. Roussel, S. T. Seremetis, M. Ohtsuka, and C. J. Sherr. 1989. Monoclonal antibodies to the human CSF-1 receptor (c-fins proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells. Blood 73:827–837.
   PubMed Web of Science ®Google Scholar
• Bertics, P. J., W. S. Chen, L. Hubler, C. S. Lazar, M. G. Rosenfeld, and G. N. Gill. 1988. Alteration of epidermal growth factor receptor activity by mutation of its primary carboxylterminal site of tyrosine self-phosphorylation. J. Biol. Chem. 263:3610–3617.
   PubMedGoogle Scholar
• Bertics, P. J., and G. N. Gill. 1985. Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. J. Biol. Chem. 260:14642–14647.
   PubMedGoogle Scholar
• Boni-Schnetzler, M., and P. F. Pilch. 1987. Mechanism of epidermal growth factor receptor autophosphorylation and high affinity binding. Proc. Natl. Acad. Sci. USA 84:7832–7836.
   PubMedGoogle Scholar
• Boni-Schnetzler, M., A. Kaligian, R. Del Vecchio, and P. F. Pilch. 1988. Ligand-dependent intersubunit association within the insulin receptor complex activates its intrinsic kinase activ- ity. J. Biol. Chem. 263:6822–6828.
   PubMedGoogle Scholar
• Cochet, C., O. Kashles, E. M. Chambaz, I. Borel Io, C. R. King, and J. Schlessinger. 1988. Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J. Biol. Chem. 263:3290–3295.
   PubMed Web of Science ®Google Scholar
• Cooper, J. A., and A. MacAuley. 1988. Potential positive and negative autoregulation of p60c-src by intermolecular autophosphorylation. Proc. Natl. Acad. Sci. USA 85:4232–4236.
   PubMed Web of Science ®Google Scholar
• Coussens, L., C. Van Beveren, D. Smith, E. Chen, R. L. Mitchell, C. M. Isacke, I. M. Verma, and A. Ullrich. 1986. Structural alteration of viral homologue of receptor protooncogene fms at carboxyl terminus. Nature 320:277–280.
   PubMed Web of Science ®Google Scholar
• Downing, J. R., C. W. Rettenmier, and C. J. Sherr. 1988. Ligand-induced tyrosine kinase activity of the colony stimulating factor-1 receptor in a murine macrophage cell line. Mol. Cell. Biol. 8:1795–1799.
   PubMed Web of Science ®Google Scholar
• Downing, J. R., M. F. Roussel, and C. J. Sherr. 1989. Ligand and protein kinase C down modulate the colony-stimulating factor-1 receptor by independent mechanisms. Mol. Cell. Biol. 9:2890–2896.
   PubMed Web of Science ®Google Scholar
• Ellis, L., E. Clauser, D. O. Morgan, M. Edery, R. A. Roth, and W. J. Rutter. 1986. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45:721–732.
   PubMed Web of Science ®Google Scholar
• Fanger, Β. O., J. E. Stephens, and J. V. Staros. 1989. High-yield trapping of EGF-induced receptor dimers by chemical crosslinking. FASEB J. 3:71–75.
   PubMedGoogle Scholar
• Furman, W. L., C. W. Rettenmier, J. H. Chen, M. F. Roussel, C. O. Quinn, and C. J. Sherr. 1986. Antibodies to distal carboxyl terminal epitopes in the v-fms-coded glycoprotein do not cross-react with the c-fms gene product. Virology 152:432–445.
   PubMed Web of Science ®Google Scholar
• Glenney, J. R., W. S. Chen, C. S. Lazar, G. M. Welton, L. M. Zokos, M. G. Rosenfeld, and G. N. Gill. 1988. Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell 52:675–684.
   PubMedGoogle Scholar
• Guilbert, L. J., and E. R. Stanley. 1980. Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells. J. Cell Biol. 85:153–159.
   PubMed Web of Science ®Google Scholar
• Guilbert, L. J., and E. R. Stanley. 1986. The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages. J. Biol. Chem. 261:4024–4032.
   PubMed Web of Science ®Google Scholar
• Heldin, C.-H., G. Backstrom, A. Ostman, A. Hammacher, L. Ronnstrand, K. Rubin, M. Nister, and B. Westermark. 1988. Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J. 7:1387–1393.
   PubMed Web of Science ®Google Scholar
• Heldin, C.-H., A. Ernlund, C. Rorsman, and L. Ronnstrand. 1989. Dimerization of B type PDGF receptors occurs after ligand binding and is closely associated with receptor kinase activation. J. Biol. Chem. 264:8905–8912.
   PubMed Web of Science ®Google Scholar
• Herrera, R., and O. M. Rosen. 1986. Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation. J. Biol. Chem. 261:11980–11985.
   PubMedGoogle Scholar
• Honegger, A., T. J. Dull, F. Bellot, E. Van Obberghen, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger. 1988. Biological activities of EGF-receptor mutants with individually altered phosphorylation sites. EMBO J. 7:3045–3052.
   PubMedGoogle Scholar
• Honegger, A. M., T. J. Dull, S. Felder, E. Van Obberghen, F. Bellot, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger. 1987. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell 51:199–209.
   PubMed Web of Science ®Google Scholar
• Honegger, A., T. J. Dull, D. Szapary, A. Komoriya, R. Kris, A. Ullrich, and J. Schlessinger. 1988. Kinetic parameters of the protein tyrosine kinase activity of EGF-receptor mutants with individually altered autophosphorylation sites. EMBO J. 7:3053–3060.
   PubMedGoogle Scholar
• Honegger, A. M., R. M. Kris, A. Ullrich, and J. Schlessinger. 1989. Evidence that autophosphorylation of solubilized recep tors for epidermal growth factor is mediated by intermolecular cross-phosphorylation. Proc. Natl. Acad. Sci. USA 86:925–929.
   PubMed Web of Science ®Google Scholar
• Kmiecik, T. E., and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65–73.
   PubMed Web of Science ®Google Scholar
• Meckling-Hansen, K., R. Nelson, P. Branton, and T. Pawson. 1987. Enzymatic activation of Fujinami sarcoma virus gag-fps transforming proteins by autophosphorylation at tyrosine. EMBO J. 6:659–666.
   PubMedGoogle Scholar
• Merrifield, R. B. 1983. Solid phase peptide synthesis. 1. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149–2154.
   Google Scholar
• Morgan, C. J., and E. R. Stanley. 1984. Chemical crosslinking of the mononuclear phagocyte specific growth factor CSF-1 to its receptor at the cell surface. Biochem. Biophys. Res. Commun. 119:35–41.
   PubMedGoogle Scholar
• Ohtsuka, M., S. Ihara, R. Ogawa, T. Watanabe, and Y. Watanabe. 1984. Preparation and characterization of antibodies to O-phosphotyrosine and their use in identification of phosphotyrosine-containing proteins. Int. J. Cancer 34:855–861.
   PubMedGoogle Scholar
• Piwnica-Worms, H., K. B. Saunders, T. M. Roberts, A. E. Smith, and S. H. Cheng. 1987. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c src. Cell 49:75–82.
   PubMed Web of Science ®Google Scholar
• Rettenmier, C. W., J. H. Chen, M. F. Roussel, and C. J. Sherr. 1985. The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity. Science 228:320–322.
   PubMedGoogle Scholar
• Rettenmier, C. W., R. Sacca, W. L. Furman, M. F. Roussel, J. T. Holt, A. W. Nienhuis, E. R. Stanley, and C. J. Sherr. 1986. Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines. J. Clin. Invest. 77:1740–1746.
   PubMed Web of Science ®Google Scholar
• Rosen, O. M., R. Herrera, Y. Olowe, L. M. Petruzzelli, and M. H. Cobb. 1983. Phosphorylation activates the insulin receptor tyrosine kinase. Proc. Natl. Acad. Sci. USA 80:3237–3240.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., J. R. Downing, C. W. Rettenmier, and C. J. Sherr. 1988. A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 55:979–988.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., J. R. Downing, and C. J. Sherr. 1990. Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains. Oncogene 5:25–30.
   PubMedGoogle Scholar
• Roussel, M. F., T. J. Dull, C. W. Rettenmier, P. Ralph, A. Ullrich, and C. J. Sherr. 1987. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature (London) 325:549–552.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., C. W. Rettenmier, A. T. Look, and C. J. Sherr. 1984. Cell surface expression of v-fms-coded glycoproteins is required for transformation. Mol. Cell. Biol. 4:1999–2009.
   PubMed Web of Science ®Google Scholar
• Seifert, R. A., C. E. Hart, P. E. Phillips, J. W. Forstrom, R. Ross, M. J. Murray, and D. F. Bowen-Pope. 1989. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J. Biol. Chem. 264:8771–8778.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1990. The colony-stimulating factor 1 receptor. Blood 75:1–12.
   PubMedGoogle Scholar
• Sherr, C. J., C. W. Rettenmier, R. Sacca, M. F. Roussel, A. T. Look, and E. R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665–676.
   PubMed Web of Science ®Google Scholar
• Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327–338.
   PubMedGoogle Scholar
• W'einmaster, G., M. J. Zoller, M. Smith, E. Hinze, and T. Pawson. 1984. Mutagenesis of Fujinami sarcoma virus: Evidence that tyrosine phosphorylation of Ρ130gag-fps modulates its biological activity. Cell 37:559–568.
   PubMedGoogle Scholar
• Woolford, J., A. McAuliffe, and L. R. Rohrschneider. 1988. Activation of the feline c-fms proto-oncogene: multiple alter ations are required to generate a fully transformed phenotype. Cell 55:965–977.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and J. Schlessinger. 1987. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26:1434–1442.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and J. Schlessinger. 1987. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26:1443–1451.
   PubMed Web of Science ®Google Scholar
• Yu, K.-T., and M. P. Czech. 1984. Tyrosine phosphorylation of the insulin receptor β subunit activates the receptor-associated tyrosine kinase activity. J. Biol. Chem. 259:5277–5286.
   PubMed Web of Science ®Google Scholar